Walleye Capital’s GenMark Diagnostics, Inc GNMK Stock Holding History

Walleye Capital’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-73,450	Closed	-$1.75K	–	1664
2021 Q1	$1.75K	Buy	+73,450	New	+$1.37M	0.1%	166

Walleye Capital's GNMK Position: Q2 2021 in Review

Walleye Capital sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 73,450 shares — an estimated $1.75K sold.

Walleye Capital first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $1.75K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Walleye Capital reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Walleye Capital sold 73,450 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.75K.
Walleye Capital first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
Walleye Capital's GenMark Diagnostics, Inc position peaked at $1.75K in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Walleye Capital's 13F filing for Q2 2021, filed 16 Aug 2021.